Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06817408 · ClinicalTrials.gov registry record
Dynamics of Organ Damage and Immune Exhaustion During Sepsis
A clinical trial of Sepsis, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06817408: Recruiting study of Sepsis, sponsored by Mayo Clinic.
NCT06817408 is a study of Sepsis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,000 participants, below the 6,554-participant average among 90 other Sepsis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06817408, a study of Sepsis, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, non-randomized study investigating if organ damage and immune changes can be measured by liquid biopsy NGS through advanced analytical methods.
Primary Outcome
Overall survival
Conditions Studied
Interventions
- OTHER Observation
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-03-25 |
| Est. Completion | 2026-12 |
What NCT06817408 shows while recruiting
NCT06817408 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 6,554-participant average among 90 other Sepsis trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.
NCT06817408 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06817408 about?
NCT06817408 is a clinical study titled "Dynamics of Organ Damage and Immune Exhaustion During Sepsis". This is a prospective, non-randomized study investigating if organ damage and immune changes can be measured by liquid biopsy NGS through advanced analytical methods.
What is the current status of trial NCT06817408?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-03-25. Estimated completion is 2026-12.
What conditions does trial NCT06817408 study?
This clinical trial studies the following conditions: Sepsis.
What interventions are being tested in trial NCT06817408?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT06817408?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06817408 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06817408's enrollment target sits among peer trials
1,000 19th of 90 higher than 72 of 90 other Sepsis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI